Melatonin Bluefish

Melatonin, the active ingredient in Melatonin Bluefish, is a melatonin receptor agonist presented as an oral supplement for oral use. It is employed to support normal sleep patterns in adults experiencing insomnia or circadian‑rhythm disturbances. GNH USA supplies Melatonin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on melatonin receptors to regulate the circadian rhythm and is used for sleep‑related disorders. - Insomnia: helps reduce sleep onset latency and improve total sleep time. - Sleep‑wake rhythm disorders: assists in aligning the internal clock with desired sleep‑wake schedules. - Delayed sleep phase syndrome: promotes earlier sleep onset and more consistent sleep timing.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Drowsiness: may persist into the next morning. - Dizziness: transient episodes. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or increased anxiety in susceptible individuals. - Hormonal effects: rare alterations in menstrual cycle or reproductive hormones.

Melatonin should be used with awareness of specific safety considerations. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a clinician. - Concomitant CNS depressants: monitor for additive drowsiness. - Anticoagulants: observe for any changes in bleeding tendency. - Underlying psychiatric conditions: use caution if prone to mood disorders. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonin may interact with several drug classes, requiring attention to potential effects.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Immunosuppressants (e.g., cyclosporine): possible reduction in efficacy.

Moderate Interactions (Monitor Closely):\n- CNS depressants (e.g., benzodiazepines, antihistamines): enhanced sedation. - Oral contraceptives: potential reduction in contraceptive effectiveness. - CYP1A2 inhibitors (e.g., fluvoxamine): elevated melatonin plasma levels. - Antidiabetic agents: monitor blood glucose for possible alterations.